Capital Flow Monitor · Sponsors · CIK 1820570
Cecelia Health Holdings, Inc.
355 LEXINGTON AVENUE, NEW YORK, NY, 10017 · 866-411-0254
Other Health Care · Corporation· inc. DELAWARE true
Fit score
—
Offering
$19.1M
Sold
$16.1M
% sold
84.3%
Investors
39
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-07-11 | D/A ·current | 506(b) | $19.1M | $16.1M | 84.3% | 39 | EDGAR ↗ |
| 2025-07-11 | D | 506(b) | $19.1M | $16.1M | 84.3% | 39 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Saul Richter — Director, New York, NY
1 other raise
- Galenus Precision Pharmacy, Inc. $5.4M of $6.6M · 81.8%
- Mark Clermont — Executive Officer / Director, New York, NY
-
Eric Edidin — Director, New York, NY
10 other raises
- BH3 Debt Opportunity Fund III-Offshore L.P. $0 of —
- BH3 Debt Opportunity Fund III L.P. $0 of —
- DOF II-Park Tower Co-Invest LLC $23.7M of $23.7M · 100.0%
- Illuminare Biotechnologies Inc $3.7M of $4.0M · 91.3%
- ILIAD BIOTECHNOLOGIES, INC. $115.5M of $115.5M · 100.0%
- BH3 Harel Debt Opportunity Fund, LP $21.0M of $21.0M · 100.0%
- BH3 Heritage FV III Feeder L.P. $15.0M of $50.0M · 30.0%
- Endo Ventures Cecelia SPV, LLC $94K of $94K · 100.0%
- Endo IV Cecelia SPV, LLC $591K of $591K · 100.0%
- Endo G100 Cecelia SPV LLC $109K of $109K · 100.0%
- Matthew Klinger — Director, New York, NY
- Richard Barasch — Director, New York, NY
-
Cody Nystrom — Director, New York, NY
2 other raises
- SJF Ventures VIA, L.P. $2.4M of —
- SJF Ventures VI, L.P. $49.1M of —
-
Charles Flicker — Director, New York, NY
1 other raise
- Cosmetic Physician Partners, LLC $40.0M of $60.0M · 66.7%
- David Lombardi — Executive Officer, New York, NY
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.